Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Pediatric Dyslipidemia

Jasmine Gujral  1 , Jyotsna Gupta  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Pediatric Dyslipidemia

Jasmine Gujral et al.
Free Books & Documents

Excerpt

Cardiovascular disease is the leading cause of mortality in the United States and many other countries worldwide. One in three deaths worldwide occurs from cardiovascular events. It is now well known that atherosclerosis begins in childhood. Dyslipidemia, when recognized and treated in childhood, can reduce the risk of premature adverse cardiovascular events and mortality. This is especially relevant in the current age with the rising rates of obesity.

Dyslipidemias are defined as a group of lipoprotein abnormalities that can result in any of the following lipid abnormalities.

  1. Elevated total cholesterol (TC)

  2. Elevated low-density lipoprotein-cholesterol (LDL-C)

  3. Elevated non-high-density lipoprotein cholesterol (HDL-C)

  4. Elevated triglycerides (TG)

  5. Decreased HDL-C

Lipid Panel: A lipid panel should ideally be done after fasting for 8-9 hours. A complete lipid panel includes direct measurement of TC, HDL-C, and TG. LDL-C is calculated in the lipid profile using the Friedewald formula (LDL-C = Total cholesterol - (Triglyceride / 5) - HDL-C).

The Friedewald formula can only be used if the TG levels are lower than 400 mg/dl. If the TG levels are higher than 400 mg/dl, LDL-C must be measured directly (Direct LDL-C). Non-HDL-C is calculated by subtracting HDL cholesterol from total cholesterol and includes all atherogenic particles, including LDL-C, VLDL-C, IDL-C, and lipoprotein(a). A fasting sample is ideal because food intake can alter triglyceride levels; the differences between fasting and nonfasting TC and HDL-C are not clinically significant.

An abnormal test should be followed by a repeat lipid profile done two weeks to 3 months later for confirmation.

Screening for Dyslipidemia

Universal Screening: Current guidelines recommend universal screening in the pediatric age group between ages 9 and 11 years and between 17 and 21 years, as per National Lipid Association and the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel.

During puberty, LDL cholesterol levels may drop physiologically. Hence screening is recommended in this age group. Universal screening is important because family history may not be reliable, and early diagnosis can make a substantial difference. For example, although the risk of premature cardiovascular disease is 20 times higher in familial hypercholesterolemia, only 20% of familial hypercholesterolemia is diagnosed.

Selective screening: This is done for children with risk factors. Screening is recommended in younger children (over two years of age) in the presence of the following: family history of hypercholesteremia or premature coronary heart disease (myocardial infarction, coronary bypass surgery in men under 55 years and women under 65 years), or presence of risk factors such as obesity, diabetes, and hypertension.

Normal values for children and definition of dyslipidemia: Lipid values in children vary by age and gender. As per the Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents, here is a table listing normal, acceptable, and borderline values for the various sub-components of a lipid panel.

These values are consistent with cut-off guidelines by the American Heart Association and the American Academy of Pediatrics.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Jasmine Gujral declares no relevant financial relationships with ineligible companies.

Disclosure: Jyotsna Gupta declares no relevant financial relationships with ineligible companies.

References

    1. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang NY, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021 Feb 23;143(8):e254-e743. - PubMed
    1. Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, Ose L, Averna M, Boileau C, Borén J, Bruckert E, Catapano AL, Defesche JC, Descamps OS, Hegele RA, Hovingh GK, Humphries SE, Kovanen PT, Kuivenhoven JA, Masana L, Nordestgaard BG, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AF, Steinhagen-Thiessen E, Stroes ES, Taskinen MR, Tybjærg-Hansen A, Wiklund O, European Atherosclerosis Society Consensus Panel Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015 Sep 21;36(36):2425-37. - PMC - PubMed
    1. Alpdemir M, Alpdemir MF. Comparison of Martin and Friedewald equation for estimated LDL-C in adults. Turk Kardiyol Dern Ars. 2021 Dec;49(8):619-626. - PubMed
    1. Langsted A, Nordestgaard BG. Nonfasting versus fasting lipid profile for cardiovascular risk prediction. Pathology. 2019 Feb;51(2):131-141. - PubMed
    1. Daniels SR, Gidding SS, de Ferranti SD, National Lipid Association Expert Panel on Familial Hypercholesterolemia Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 Jun;5(3 Suppl):S30-7. - PubMed

Publication types

LinkOut - more resources